EQS-News: AUSTRIACARD HOLDINGS AG / Key word(s): Contract INFORM LYKOS SA (member of AUSTRIACARD HOLDINGS AG): Paving the Way for a New Era in Healthcare with the Digitization of the Public Health System 25.04.2024 / 10:48 CET/CEST The issuer is solely responsible for the content of this announcement. Press Release AUSTRIACARD HOLDINGS AG, a leading provider of secure digital technology solutions, is taking center stage in Greece through its subsidiary INFORM, with a pivotal project that will transform the Public Health System. By undertaking the digitization of its arch...
EQS-News: AUSTRIACARD HOLDINGS AG / Schlagwort(e): Vertrag INFORM LYKOS SA (Mitglied der AUSTRIACARD HOLDINGS AG): Wegbereiter einer neuen Ära im Gesundheitswesen durch die Digitalisierung des öffentlichen Gesundheitssystems 25.04.2024 / 10:48 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Pressemitteilung Die AUSTRIACARD HOLDINGS AG, ein führender Anbieter von sicheren digitalen Technologielösungen, steht in Griechenland mit ihre Tochtergesellschaft INFORM im Mittelpunkt eines entscheidenden Projekts, das das öffentliche Gesundheit...
>A 5% beat on operating profit and 26% on adjusted net income - Q1 2024 adjusted EBIT came in at $ 7.53bn (vs $ 8.68bn in Q4; -13.2% q-o-q), 4% above our estimates and 5% ahead of consensus. Production declined by 1.3% q-o-q and was in line with expectations and expected to remain flat in 2024 vs 2023. Adjusted net income was robust at $ 2.574bn (vs $ 1.88bn in Q4), 26% above the consensus with a lower-than-expected effective tax rate at 65.8% vs 72% expected. §h...
Correction: DOVRE GROUP TRADING STATEMENT JANUARY 1 – MARCH 31, 2024 Dovre Group Plc Stock exchange release April 25, 2024, at 9.15 a.m. DOVRE GROUP TRADING STATEMENT JANUARY 1 – MARCH 31, 2024 Significant write-down of a single renewable project led to a negative operating profit Correction: PDF attachments have been added. Dovre Group Plc issues today a trading statement for the three months ended on March 31, 2024. The figures presented in this trading statement are not audited. Last year’s corresponding period in p...
Korjaus: DOVRE GROUPIN LIIKETOIMINTAKATSAUS 1.1.–31.3.2024 Dovre Group Oyj Pörssitiedote 25.4.2024 klo 9.15 DOVRE GROUPIN LIIKETOIMINTAKATSAUS 1.1.–31.3.2024 Merkittävä alaskirjaus yksittäisen uusiutuvan energian projektista johti negatiiviseen liiketoiminnan tulokseen. Korjaus: PDF-liitteet on lisätty. Dovre Group Oyj julkistaa tänään konsernin liiketoimintakatsauksen kaudelta 1.1.–31.3.2024. Tämän liiketoimintakatsauksen luvut ovat tilintarkastamattomia. Suluissa edellisvuoden vastaavan ajankohdan vertailuluvut. T...
>Un peu supérieur aux attentes - Sanofi publie ce matin ses résultats du T1 24 qui s’avèrent un peu au-dessus des attentes au niveau des ventes et de son BPA. Comme attendu Sanofi bénéficie d’un effet changes très négatif (-4.3% en topline et -10.2% en bottom line). Brièvement, les ventes totales du groupe ressortent à 10 464 M€ vs 10 272 M€e (+2.4% ; +6.7% à tcc), son core EBIT à 2 843 M€ vs 2 748 M€e (-14.7% ; -4.2% tcc) pour un Core BPA de 1.78 € vs 1.71 €e e...
>Q1 revenue ahead of expectations: € 2,225.5m vs € 2,144.5m estimated - For its first quarter, the SPIE Group has reported revenue slightly ahead of expectations. Revenue increased by 11.6% to € 2,225.5m, compared with our estimate of € 2,144.5m (+3.8% difference) and the consensus estimate of € 2,167m (+2.7% difference). Most of the difference relates to organic growth, which was 6.2%, an excellent performance (we were expecting +4.3% and the consensus +5.2%). Acquis...
>Conclusion: Revenue in line but no beat, better cost, lower price & more volume - In 1Q24 the net revenue growth of +21% was in line with out and market consensus, but there was no beat which the market often would appreciate. Further in Q1 Adyen had less FTE than expected indicating a better cost control. Further we see luckily see that Adyen is willing to accept a lower price which is offset by getting more volume/TPV also influenced by getting a larger part of it...
Net Asset Value(s) WisdomTree Issuer plc – Daily Fund Prices 24-April-24 WisdomTree Artificial Intelligence UCITS ETF - USD Acc24/04/2024IE00BDVPNG1314054630USD845,390,073.4960.1503WisdomTree AT1 CoCo Bond UCITS ETF - EUR Hedged24/04/2024IE00BFNNN2361662036EUR135,999,021.0681.8268WisdomTree AT1 CoCo Bond UCITS ETF - GBP Hedged24/04/2024IE00BFNNN459171509GBP14,692,888.8185.6683WisdomTree AT1 CoCo Bond UCITS ETF - USD24/04/2024IE00BZ0XVF52703178USD57,599,317.7581.9129WisdomTree AT1 CoCo Bond UCITS ETF - USD Acc24/04/2024IE00BZ0XVG6950789USD5,708,431.12112.395WisdomTree...
TTM Technologies Celebrates the Grand Opening of Its First Manufacturing Facility in Penang The new facility is designed to meet the growing need to improve the resilience of the printed circuit board supply chain and expand geographic diversity PENANG, Malaysia, April 25, 2024 (GLOBE NEWSWIRE) -- TTM Technologies, Inc. (NASDAQ: TTMI) (“TTM”), a leading global manufacturer of technology solutions including mission systems, radio frequency (“RF”) components and RF microwave/microelectronic assemblies, and quick-turn and technologically advanced printed circuit boards (“PCB”s), officially...
EQS-News: Berliner Effektengesellschaft AG / Schlagwort(e): Jahresergebnis Berliner Effektengesellschaft AG veröffentlicht Einzel- und Konzernabschluss 2023 25.04.2024 / 10:19 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Berlin, 25. April 2024 Berliner Effektengesellschaft AG veröffentlicht Einzel- und Konzernabschluss 2023 Nachdem nun auch der Konzernabschluss der Berliner Effektengesellschaft testiert vorliegt, sind sowohl Einzelabschluss als auch Konzernabschluss der Berliner Effektengesellschaft AG auf der Webseite der ...
>Q1 revenues come out in line with expectations - Crit’s Q1 revenues came to € 584.5m (€ 582.1m est.) vs € 583m the previous year, up +0.3% and +0.1% organic. This reflects a challenging start to the year for the Temporary Work market, following on from similar conditions at the end of last year. TW revenues thus reached € 468.3m (€ 470.2m est.) vs € 479.8m the previous year, down -2.4% and -2.5% organic but -1% at constant number of trading days (TDA, or trading days...
A director at Sonder Holdings Inc sold 4,371 shares at 0.000USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...
>T1 2024 : CA en hausse de 5% et marge d’EBIT de 6.7% (+120 pb) - Vossloh a publié ce matin des résultats T1 2024 supérieurs aux attentes au niveau de l’EBIT.Les prises de commandes atteignent 350 M€ (+2% vs T1 2023) avec de fortes commandes aux Etats-Unis (Class I et Amtrak) et pour Lifecycle Solutions (Chine et Europe du Nord).Le chiffre d’affaires atteint 269 M€ (consensus à 265 M€), en croissance de 5%. Notons une stabilité de l’activité pour Core Compon...
>Robust margin evolution, ahead of our numbers and the consensus - Overall, Ebro’s Q1 is again a very solid quarter in operational terms (beating both ours and the consensus numbers) as it has been able to consolidate previous RSP increases and keep (or even increase) its market share in a trade-down scenario. As a result, Rice shows a +0.5pp y-o-y margin expansion while Pasta is delivering a material margin expansion (+6.5pp y-o-y). Net profit shows a robust +23% y-o...
>CA 3% au-dessus des attentes de la place - Après avoir publié le 9 avril son trafic navettes pour le T1 2024, Getlink a publié un CA T1 à 391 M€, en baisse de 23% par rapport au T1 2023 (au-dessus de nos attentes de 353 M€ et 3% du consensus à 380 M€). Pénalisé par un trafic VL encore 6% inférieur au niveau du T1 2023 et -2% pour les PL, le CA navettes ressort 5% inférieur au T1 2023 compte tenu de la guerre des prix avec les ferrys. Le CA ferroviaire ressort lu...
>Mr Di Napoli devient CEO du groupe - Cosmo Pharmaceuticals annonce ce matin la nomination de Giovanni Di Napoli au poste de CEO, en remplacement d’Alessandro Della Chà. Cette nomination sera effective lors de l’AGM prévu le 24 mai prochain. Cette nomination fait suite à son Capital Market Day réalisé en mars dernier exposant les prochaines étapes de la société et ses ambitions. Mr Di Napoli connait bien la plateforme GI Genius car vient de Medtronic où il a occ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.